Improving transformation frequency in maize

Opening the door for high-efficiency gene-editing research

Ghent,Belgium 25/06/2024Maize is one of the classical model organisms for genetic research. However, the low transformation frequency remains an important bottleneck for many gene-editing applications. Researchers at the VIB-UGent Center for Plant Systems Biology have made substantial strides in overcoming this bottleneck. By leveraging a combination of ternary vectors and morphogenic regulators, they have significantly boosted transformation efficiency, paving the way for more effective research and innovative applications. Their research is published in The Plant Journal.

Tackling the transformation bottleneck

Maize (Zea mays L.) is a very important crop globally for agricultural and industrial applications, but also a key model organism in genetic research. Traditionally, gene editing in maize relies on Agrobacterium-mediated transformation. However, a low transformation frequency in this species creates a bottleneck in genetic research, including novel genomic techniques (NGTs)

A research team from the VIB-UGent Center for Plant Systems Biology together with a collaborator at the University of Caliornia at Davis in the US, tackled this bottleneck on two fronts. They introduced an additional helper plasmid to Agrobacterium, increasing its ability to transfer DNA to maize cells.. Additionally, they used GRF-GIF chimeras, a type of morphogenic regulator, to increase the regeneration of transformed cells into plants. Combining these technologies, the number of transformed plants they could generate improved up to 20-fold.

Increasing the transformation frequency has been a goal for many research groups worldwide. However, earlier published results are often based on just a one-off experiment. Here, we evaluated our methods over many years, experiments, and operators. ​ This gives us a solid scientific foundation to implement our findings in further research. – Laurens Pauwels, group leader at the VIB-UGent center for Plant Systems Biology.
Part of the research team, from left to right: Laurens Pauwels, ​ Stijn Aesaert, Wout Vandeputte, and ​ Griet Coussens

Implications for the future

The research was done on a maize inbred line called B104. Although this line is often used in research, it has limited economic benefits for agriculture in Belgium. The inbred line is not well-suited to local growing conditions, and farmers typically use hybrids. The researchers now aim to transform maize inbred lines. The final goal is to gain knowledge to create new hybrids that are agronomically viable and economically beneficial for local farmers, but are difficult to transform with older methods.

Our next focus will be on field applications. If we can transform inbred maize lines that are more interesting for farmers, we might be able to create more interesting hybrid plants. This can be the starting point to use NGTs more efficiently in agriculture. – Wout Vandeputte, first author and PhD student at the VIB-UGent Center for Plant systems Biology.

Publication: http://doi.org/10.1111/tpj.16880

Funding: ​ FWO and Methusalem funding


About the VIB-UGent Center for Plant Systems Biology

The VIB-UGent Center for Plant Systems Biology wants to gain insight into how plants grow and respond to the environment. Scientists study how leaves and roots are formed, which micro-organisms live on and around the plant and which substances the plant makes. They map out the genetic diversity of the plant kingdom. This knowledge can lead to sustainable innovations in agriculture and food.

 

 

 

 

Share

Latest stories

Website preview
RSV vaccines could offer protection against asthma
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have found that early-infancy infection with respiratory syncytial virus (RSV) increases the risk of developing childhood asthma
press.vib.be
Website preview
New immune process identified that may alleviate Alzheimer's disease
26 November 2025, Leuven, Belgium - Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer’s disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have now demonstrated the mechanism behind it for the first time. They showed that the ‘Fc fragment’ of this monoclonal antibody is essential for engaging microglia - the immune cells of the brain -, thus initiating the cellular machinery needed for plaque removal. This is the first direct mechanistic explanation for how this class of therapies works. It clarifies uncertainties in the field and offers a blueprint for developing safer, more effective Alzheimer’s treatments. The findings are published in Nature Neuroscience.
press.vib.be
Website preview
Belgian collaboration drives new momentum in amyloidosis care and research 
World Amyloidosis Day – 26 October | First benefit concert supports new Fund 
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be